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le1 is required for mRNA export in yeast and human
cells. Here, we report that two human Gle1 (hGle1)
isoforms are expressed in HeLa cells (hGle1A and
B). The two encoded proteins are identical except for their
COOH-terminal regions. hGle1A ends with a unique four–
amino acid segment, whereas hGle1B has a COOH-terminal
43–amino acid span. Only hGle1B, the more abundant
isoform, localizes to the nuclear envelope (NE) and pore
complex. To test whether hGle1 is a dynamic shuttling
transport factor, we microinjected HeLa cells with recom-
binant hGle1 and conducted photobleaching studies of live
HeLa cells expressing EGFP–hGle1. Both strategies show
G
 
that hGle1 shuttles between the nucleus and cytoplasm. An
internal 39–amino acid domain is necessary and sufﬁcient
for mediating nucleocytoplasmic transport. Using a cell-
permeable peptide strategy, we document a role for hGle1
shuttling in mRNA export. An hGle1 shuttling domain (SD)
 
peptide impairs the export of both total poly(A)
 
 
 
 RNA and
the speciﬁc dihydrofolate reductase mRNA. Coincidentally,
SD peptide–treated cells show decreased endogenous
hGle1 localization at the NE and reduced nucleocytoplasmic
shuttling of microinjected, recombinant hGle1. These ﬁndings
pinpoint the ﬁrst functional motif in hGle1 and link hGle1
to the dynamic mRNA export mechanism.
 
Introduction
 
mRNAs undergo a number of processing and maturation
events between their transcription by polymerases and their
ultimate translation by ribosomes (Maniatis and Reed,
2002). In eukaryotic cells, a key step involves export to the
cytoplasm through nuclear pore complexes (NPCs)* embedded
in the nuclear envelope (NE) (Nakielny and Dreyfuss, 1999;
Wente, 2000). The export of mRNAs is a stepwise process
(Maniatis and Reed, 2002) beginning with the processing of
pre-mRNAs into heterogeneous nuclear ribonucleoprotein
(hnRNP) complexes that are recognized by transport receptors
in the nucleoplasm. The transporters subsequently target the
mRNA-bound hnRNP complex (mRNP) to the NPC and
mediate translocation through the NPC for release on the
cytoplasmic side. The transporters and the hnRNPs are
subsequently reimported into the nucleus and, thus, are
considered dynamic shuttling factors.
The molecular paradigms for this pathway were initially
established from studies of viral RNA export (Cullen, 2000;
Hammarskjold, 2001). For the HIV-1 pathway, a nuclear
export sequence (NES) in the RNA-bound viral Rev protein
is recognized by Crm1 (Fischer et al., 1999), a member of a
conserved family of transport receptors called karyopherins
(also designated exportins/importins/transportins) (Gorlich
and Kutay, 1999). Through interaction with specific adaptor
proteins, Crm1 also mediates the export of cellular RNAs,
such as 5S RNA and U1 snRNA (Fischer et al., 1995), and
the 60S ribosomal subunit (Ho et al., 2000). A different
karyopherin (exportin-t/Los1) mediates the export of tRNA
(Gorlich and Kutay, 1999).
Karyopherins may play multiple roles in the export of
mRNPs (Yi et al., 2002), some being required for the export
of cellular mRNAs from early response genes (Gallouzi and
Steitz, 2001; Gallouzi et al., 2001). Distinct sets of importins
are needed for the reimport of shuttling hnRNPs (Michael
et al., 1995, 1997). However, studies in yeast, mammalian,
and 
 
Xenopus
 
 oocyte systems have illustrated a central role for
the novel Mex67/TAP/NXF1 protein (Segref et al., 1997;
Gruter et al., 1998; Katahira et al., 1999). In higher eukaryotes,
splicing and TAP/NXF1-mediated nuclear export are be-
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lieved to be coupled (Maniatis and Reed, 2002). TAP/
NXF1, together with its cofactor p15/NXT1 (Fribourg, et
al., 2001), promotes the export of both spliced and intron-
less transcripts through interactions with both mRNPs and
NPC proteins (Maniatis and Reed, 2002). Thus, TAP/
NXF1 may act as a shuttling bridge between the mRNP
complex and the NPC (Zenklusen and Stutz, 2001). Al-
though TAP/NXF1 was shown to cooperate with karyo-
pherins (Shamsher et al., 2002), TAP/NXF1 itself does not
bind Ran, and RanGTP hydrolysis is not required for TAP/
NXF1-mediated mRNA export (Bachi et al., 2000).
Several other factors are also required for mRNA export,
including the DEAD-box RNA helicase Dbp5 and two
NPC-associated factors Gle1 and Gle2/Rae1 (Zenklusen
and Stutz, 2001; Reed and Hurt, 2002). Dbp5 may remodel
hnRNP complexes at the NPC and mediate the release of
nonshuttling hnRNPs in the nucleus and shuttling hnRNPs
in the cytoplasm. This could serve a critical role in mRNP
transport directionality (Snay-Hodge et al., 1998; Tseng et
al., 1998; Schmitt et al., 1999; Zhao et al., 2002). Work
from several groups strongly supports the hypothesis that
Gle1 plays an essential role in mRNA export (Del Priore et
al., 1996; Murphy and Wente, 1996; Noble and Guthrie,
1996; Watkins et al., 1998). Human Gle1 (hGle1) and 
 
Sac-
charomyces cerevisiae
 
 Gle1 (scGle1) have no consensus RNA
binding sites, and no functional protein motifs have been
definitely identified (Reed and Hurt, 2002). Moreover, no
hGle1-interacting proteins have been identified. Genetic
connections implicate scGle1 as a modulator of scDbp5 ac-
tivity (Hodge et al., 1999), and scGle1 also interacts with
Nup42 (Murphy and Wente, 1996; Stutz et al., 1997;
Strahm et al., 1999), Dbp5, and a nonessential factor, Gfd1
(Hodge et al., 1999; Strahm et al., 1999). Recently, our
studies in yeast have shown that soluble inositol hexakispho-
sphate production is required for efficient scGle1 function
(York et al., 1999). Overall, how Gle1 mediates nuclear
transport is far from being resolved.
A long-standing question regarding Gle1 function is
whether it is a dynamic shuttling factor or a stable compo-
nent of the NPC (a nucleoporin). Others have suggested
that scGle1 is a static nucleoporin (Rout et al., 2000). How-
ever, the mammalian Gle1 protein does not cofractionate
with NPCs (Cronshaw et al., 2002). Here, we have focused
on the human protein. We demonstrate that two hGle1 pro-
tein variants (hGle1A and B) are encoded from a single
gene. The hGle1B isoform associates with the NE/NPC in
HeLa cells and is the predominant variant. We subsequently
show that both proteins can shuttle between the nucleus and
cytoplasm and that this shuttling activity requires the pres-
ence of a novel 39–amino acid domain. Moreover, using a
cell-permeable peptide strategy, we found that hGle1 shut-
tling is essential for poly(A)
 
 
 
 RNA export.
 
Results
 
Human Gle1 cDNAs encode two isoforms 
in HeLa cells
 
Previous studies have shown endogenous hGle1 localization
at the NPCs/NE and in the cytoplasm and nucleus (Watkins
et al., 1998; Fig. 1 A). Here we show that ectopic expression
of the hGle1 cDNA previously reported by Watkins et al.
(1998), in fusion with EGFP, did not produce a protein that
localized predominately to the NE of transfected cells (Fig. 1
A). We speculated that this isoform (hereafter designated
hGle1A, a 659–amino acid polypeptide; accession no.
AAC25561) lacked a critical region required for NPC/
NE association. Recently, a human testis cDNA clone
was deposited in the human EST database (accession no.
AAH30012). The predicted protein product is a 698–amino
acid polypeptide (designated hGle1B) identical to hGle1A
except at the COOH terminus (Fig. 1, B and D). Based on
genomic sequence information (Locus ID 2733), the 
 
hGle1
 
gene is comprised of 16 exons. Within exon 14, a 5
 
 
 
 cryptic
splice donor site could account for the expression of two
transcript variants, with two corresponding different 3
 
 
 
 un-
translated regions (Nissim-Rafinia and Kerem, 2002). The
predicted products result in the hGle1A version with a
unique four–amino acid segment and hGle1B with a differ-
ent 43–amino acid span at the COOH terminus (Fig. 1 D).
To determine if HeLa cells express these two mRNA iso-
forms, we performed semiquantitative PCR studies on total
HeLa cDNA (Fig. 1 C). Using a forward (F) primer com-
mon to both variants and isoform-specific reverse primers (A
and B, respectively; Fig. 1 B), we found that HeLa cells ex-
pressed both the short (hGle1A) and long (hGle1B) iso-
forms and that hGle1B mRNA was 
 
 
 
1,000-fold more
abundant than hGle1A. By Northern blotting, the preferen-
tial expression of the hGle1B mRNA over hGle1A was also
detected in all human tissues analyzed (unpublished data).
Finally, ectopic expression experiments in HeLa cells re-
vealed that EGFP–hGle1B localization was similar to en-
dogenous hGle1 (Fig. 1 A). These results argue that hGle1B
is the prevalent isoform in human cells.
 
Identifying an hGle1 domain 
with nuclear export activity
 
We speculated that if hGle1 is dynamic and transiently asso-
ciates with NPCs while entering and exiting the nucleus, it
should contain domains/sequences that harbor nucleocyto-
plasmic transport activities. The region of hGle1 spanning
amino acid residues 444–606 was specifically targeted for in-
ternal in-frame deletion based on our previous studies of
scGle1 (Murphy and Wente, 1996; Watkins et al., 1998).
The COOH-terminal regions of scGle1 and hGle1A/B are
highly similar, and the corresponding region in scGle1 con-
tains a putative leucine-rich (LR) NES-like motif that is es-
sential for scGle1 function in mRNA export (Fig. 1 D; see
Discussion). As a tool to delineate the region(s) of hGle1
that may harbor nuclear export activity, we generated a
panel of ectopically expressed FLAG-tagged hGle1A dele-
tion proteins and analyzed their respective intracellular dis-
tributions independent of the endogenous hGle1 by indirect
immunofluorescence (IIF) using anti-FLAG antibodies. To
assay for export activity, we placed the SV40 large T antigen
NLS in frame at the COOH terminus of FLAG–hGle1A.
Based on the hypothesis that hGle1 harbors nuclear export
activity, it should balance the activity of the heterologous
NLS and result in cytoplasmic FLAG–hGle1A–NLS local-
ization. Results from these experiments are summarized in
Fig. 2. Although the majority of the FLAG–hGle1A–NLST
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was detected in the nucleus, FLAG–hGle1A–NLS was also
clearly present in the cytoplasm (Fig. 2, lower left). Strik-
ingly, the FLAG–hGle1A
 
 
 
444–606
 
–NLS protein was localized
exclusively in the nucleus. Various NH
 
2
 
- and COOH-ter-
minal deletions of the 444–606 region were tested to map
the export activity. Deletions from the NH
 
2
 
-terminal side
eliminated cytoplasmic localization (
 
 
 
444–511), whereas
deletions from the COOH-terminal side up to residue 483
retained the export activity (
 
 
 
484–606) (Fig. 2). Thus, a
39–amino acid region from residues 444–483 was necessary
to confer cytoplasmic localization of FLAG–hGle1A–NLS.
 
The 39–amino acid region of hGle1 has intrinsic 
nucleocytoplasmic shuttling activity
 
To further examine the transport properties of the 39–
amino acid hGle1 region defined above, we conducted a
series of microinjection experiments with bacterially ex-
pressed and purified GST fusion proteins (Fig. 3). Binucle-
 
ate HeLa cells were used for nuclear microinjection such
that the export and nucleocytoplasmic shuttling activities
of GST fusion proteins could be coincidentally examined.
First, a GST fusion with only the 39–amino acid putative
domain (hGle1
 
444–483 (SD)
 
) was tested by coinjection with
Texas red (TR)–labeled 70-kD dextran into one nucleus of
a binucleate HeLa cell (Fig. 3 A). The TR–dextran identi-
fied injected cells and the subcellular injection site (arrows).
The cells were subsequently incubated at either 37
 
 
 
C (Fig.
3 A, left) or 4
 
 
 
C (right), fixed, and processed for IIF
microscopy with anti-GST antibodies. At 37
 
 
 
C, 86.5%
(
 
 
 
2.8%; 
 
n
 
 
 
 
 
112) of the microinjected cells showed GST–
hGle1
 
444–483 (SD)
 
 at the injection site, in the cytoplasm, and
in the second nucleus (Fig. 3 A, arrowhead). In contrast, at
4
 
 
 
C, GST–hGle1
 
444–483 (SD)
 
 remained at the site of injection
in 87% (
 
 
 
4.3%; 
 
n
 
 
 
 
 
 81) of the injected cells. These re-
sults indicated that GST–hGle1
 
444–483 (SD)
 
 was actively ex-
ported from the injected nucleus. In time course experi-
Figure 1. hGle1 encodes two mRNA isoforms in HeLa cells. (A) Intracellular localization of endogenous hGle1 (top; using anti-hGle1 antibodies; 
Watkins et al., 1998), ectopically expressed EGFP–hGle1A (middle), and EGFP–hGle1B (bottom) in fixed HeLa cells (Fix-Triton; see Materials 
and methods). Double IIF with mAb414 was used to detect NPC/NE localization. Bar, 10  m. (B) Schematic representation of hGle1. Exons 
are boxed, numbered 5  to 3 , with nos. 15 and 16 specific to hGle1B (gray boxes). Primers used to specifically amplify hGle1A and hGle1B 
in RT-PCR experiments are F (common forward primer), A (hGle1A 3  UTR–specific reverse primer), and B (hGle1B-specific reverse primer). 
(C) Semiquantitative RT-PCR analysis of hGle1A and hGleB mRNA levels in HeLa cells. Serial dilutions of total HeLa cell cDNA were tested 
using primer combinations F/A and F/B for hGle1A and hGle1B, respectively. Amplification products (202 bp and 180 bp, respectively) were 
separated on agarose gel and stained with ethidium bromide. Similar intensities at cDNA dilutions of 10
 2 for hGle1A and 10
 5 for hGle1B 
(arrowheads) suggest that hGle1B mRNA is 10
3-fold more abundant. (D) Sequence comparison (ClustalW) of the COOH-terminal regions of 
scGle1, hGle1A, and hGle1B (Pearson and Lipman, 1988). Boxed region 444–483 of hGle1A/B harbors shuttling activity. The putative LR-NES 
in scGle1 is double underlined. The unique four amino acids of hGle1A are underlined. *, identical residues; : or ., conserved residues.T
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ments, export was detected at full levels within 2 h after
injection (unpublished data). Thus, residues 444–483 of
hGle1 were sufficient to mediate nuclear export. In addi-
tion, the presence of GST–hGle1
 
444–483 (SD)
 
 in the second
nucleus of binucleate cells suggested that this region also
had nuclear import activity. These experiments support the
hypothesis that hGle1 harbors a nucleocytoplasmic trans-
port domain, for both import and export. Hence, we have
designated this 39–amino acid span the hGle1 nucleocyto-
plasmic shuttling domain (SD).
To analyze the nucleocytoplasmic shuttling of full-length
hGle1, GST–hGle1B and GST–hGle1A (unpublished data)
were microinjected into the cytoplasm or nucleus of HeLa
cells. After incubation at 37
 
 
 
C, protein localization was de-
termined by IIF. Fig. 3 B shows that GST–hGle1B was ex-
ported from the injected nucleus and imported into the sec-
ond nucleus (left panel, arrowhead) in 84% (
 
 
 
2.1%; 
 
n
 
 
 
 
 
56) of the injected cells. Nuclear import activity of GST–
hGle1B was also detected after cytoplasmic injection of the
protein (asterisk). The transport activities appeared to be en-
ergy dependent, as shown by the lack of redistribution when
incubated at 4
 
 
 
C (Fig. 3 B, right).
To independently test whether hGle1 shuttles, we ana-
lyzed the dynamics of EGFP–hGle1B in live HeLa cells (Fig.
3 C). This was based on our observation that ectopically ex-
 
pressed EGFP–hGle1B localizes like endogenous hGle1
(Fig. 1 A). Using the technique of fluorescence loss in pho-
tobleaching (FLIP), we analyzed whether nuclear EGFP–
hGle1B could exchange with the cytoplasmic pool of
EGFP–hGle1B. By repeatedly bleaching an area of the cyto-
plasm, the decrease in nuclear EGFP fluorescence over time
was monitored. As controls, the same bleach protocol was
conducted on EGFP–human coilin (a nonshuttling protein)
and EGFP–hNup98 (a mobile nucleoporin) transfected cells
(Griffis et al., 2002). Our results show that EGFP–hGle1B
nuclear fluorescence was lost by repetitive cytoplasmic
bleaching, similar to EGFP–hNup98. In contrast, 
 
 
 
9% of
nuclear EGFP–coilin fluorescence was lost in the same time
frame. Thus, these experiments corroborate the microinjec-
tion results and demonstrate that hGle1B harbors nucleocy-
toplasmic shuttling activity.
To test whether the 39–amino acid region from residues
444–483 was required for hGle1 shuttling, we attempted
to analyze the dynamics of EGFP–hGle1B
 
 
 
SD
 
 in live
HeLa  cells. Unfortunately, ectopic expression of EGFP–
hGle1B
 
 
 
SD
 
 was toxic to the cells (unpublished data). Thus,
GST–hGle1B
 
 
 
SD
 
 was purified and microinjected into one
nucleus of binucleate HeLa cells (Fig. 3 D, left). After incu-
bation at 37
 
 
 
C for 5 h, GST–hGle1B
 
 
 
SD
 
 was detected only
in the injected nucleus in 87.8% (
 
 
 
6.7%; 
 
n
 
 
 
 
 
 52) of in-
jected cells. GST–hGle1B
 
 
 
SD
 
 was also microinjected into the
cytoplasm of HeLa cells and detected in the nucleus in
89.4% (
 
 
 
2.5%; 
 
n
 
 
 
 
 
 55) of cases (Fig. 3 D, right, asterisk).
However, over the same time frame after injection, the nu-
clear signal was not nearly as intense as with GST–hGle1B
(Fig. 3, B and D, asterisk). We concluded that GST–
hGle1B
 
 
 
SD
 
 did not have nuclear export activity, and any re-
maining domain(s) had weak nuclear localization activity.
The SD may provide the primary nuclear import pathway
(see below). Similar experiments were conducted using
GST–hGle1A and GST–hGle1A
 
 
 
SD
 
 and showed identical
results (not depicted).
 
The SD of hGle1 is required for hGle1-dependent 
mRNA export
 
Our previous studies have shown that hGle1 is required for
the export of poly(A)
 
 
 
 RNA in HeLa cells (Watkins et al.,
1998). We speculated that hGle1 nucleocytoplasmic shut-
tling may be important for its transport function and that
this role may be mediated by the interaction of the SD with
another factor in the poly(A)
 
 
 
 RNA export pathway. To in-
vestigate this hypothesis, we used a cell-permeable peptide
strategy that is based on inhibiting protein–protein interac-
tions (Pritchard et al., 1999). We reasoned that by compet-
ing for the factor(s) required for hGle1 transport, we would
abrogate the shuttling of endogenous hGle1. We would
then be able to study the effect of a “static” hGle1 on total
poly(A)
 
 
 
 RNA distribution within the cell by in situ hybrid-
ization. A similar strategy was used by Gallouzi and Steitz
(2001) in a study of mRNA export pathways.
To test this hypothesis, a peptide corresponding to the
SD was synthesized as a COOH-terminal fusion to a 16–
amino acid portion of helix 3 from the homeodomain of
the 
 
Drosophila
 
 transcription factor antennapedia (Prochi-
antz, 1999), designated AP–hGle1-SD (Fig. 4 A). The an-
Figure 2. Delineating the hGle1 domain with nuclear export activity. 
(Top) Schematic representation and summary of the intracellular 
localizations for FLAG–hGle1A–NLS deletion constructs. C, 
cytoplasmic localization; N, nuclear localization; *, representative 
localization below. (Bottom) IIF localization of representative 
FLAG–hGle1–NLS proteins after transient expression in HeLa cells. 
Anti-FLAG monoclonal antibodies (top row) and staining for nuclear 
DNA with DAPI (bottom row) are shown. The cells in each figure 
are representative of the localization seen in the majority ( 70%; 
n   500) of the cells across the total population of transfectants. 
Bar, 10  m.T
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tennapedia peptide (AP) sequence mediates the uptake of
peptides into cells and confers stability (Derossi et al.,
1996, 1998). As a control, an AP fusion peptide was also
synthesized with a randomly scrambled sequence of the
same amino acid composition as the SD (designated AP–
hGle1-scrSD; Fig. 4 A). As seen in Fig. 4 B, incubating
cultured HeLa cells (at 
 
 
 
10 passages, see Materials and
methods) with media containing 5 
 
 
 
M AP–hGle1-SD
peptide had distinct effects. After 4 h in the presence of
AP–hGle1-SD peptide, 
 
 
 
5% of cells appeared to undergo
apoptosis (asterisk). Interestingly, all the remaining inter-
phase cells showed marked accumulation of poly(A)
 
 
 
 RNA
in the nucleus. In contrast, no cytotoxicity was detected
with the AP–hGle1-scrSD incubation, and all the cells
showed normal poly(A)
 
 
 
 RNA distribution by in situ hy-
bridization (untreated control cells in Fig. 4 C). In culture
media with 
 
 
 
10% FBS or with AP–hGle1-SD peptide
concentrations 
 
 
 
5 
 
 
 
M, the viability of the cells was drasti-
cally reduced. However, if the inhibitory peptide was re-
moved after the 4-h incubation, the cells recovered and
showed normal poly(A)
 
 
 
 RNA distribution after 12 h (not
depicted).
Figure 3. Analysis of GST–hGle1 
dynamics in HeLa cells by microinjection. 
(A) The hGle1 39–amino acid region 
from 444–483 has intrinsic nucleocyto-
plasmic shuttling activity. HeLa cells 
were comicroinjected with purified 
proteins and TR-labeled 70-kD dextran. 
Cells were incubated for 5 h at 37 C or 
4 C after injection and processed for IIF 
microscopy using anti-GST antibodies 
(top). Nuclear DNA was stained with 
DAPI (bottom). At 37 C (left), micro-
injection of GST–hGle1444–483 (SD) in one 
nucleus of a binucleate HeLa cell (top, 
arrow), as indicated by the TR-labeled 
dextran (middle), results in GST staining 
in the second nucleus (arrowhead). At 
4 C (right), nuclear export and import 
activity of GST–hGle1444–483 (SD) is not 
detected. (arrow, nuclear injection; 
asterisk, cytoplasmic injection). (B and 
D) The SD is necessary for GST–hGle1B 
export. Full-length GST–hGle1B (B) and 
GST–hGle1 SD (D) were analyzed by
microinjection. (B) After injection into 
one nucleus of a binucleate cell (arrow-
head), GST–hGle1B is in both the cyto-
plasm and the uninjected nucleus after 
incubation at 37 C (right). Cytoplasmically 
microinjected GST–hGle1B (asterisk) 
shows strong nuclear staining. At 4 C 
(left), injected protein remains at the site 
of microinjection. (C) FLIP analysis 
reveals that EGFP–hGle1B shuttles 
between the nucleus and cytoplasm in 
HeLa cells. An area of the cytoplasm 
was repeatedly bleached, and the loss 
of nuclear fluorescence was monitored 
over time. The data points plotted for 
EGFP–hGle1B represent averages (n   6). 
EGFP–coilin and EGFP–hNup98 data are 
representative of the loss of fluorescence 
detected in several time courses and are 
consistent with data previously reported 
(Griffis et al., 2002). (D) Microinjection 
of GST–hGle1B SD protein in the nucleus 
results in no staining outside the micro-
injection site after incubation at 37 C 
(both panels) (or 4 C; not depicted). In 
the right panel, partial nuclear localization 
is observed in two cytoplasmically 
injected cells (asterisks). Bars, 10  m.T
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To ensure that the increase in nuclear poly(A)
 
  RNA
levels did not reflect a perturbation in the polyadenylation
process, we also analyzed the export of an individual
mRNA. In situ hybridization experiments using a dihy-
drofolate reductase (DHFR) mRNA–specific digoxigenin-
labeled antisense oligonucleotide were conducted. Incuba-
tion with the AP–hGle1-SD peptide resulted in nuclear
accumulation of DHFR mRNA (Fig. 4 D). In contrast,
the control AP–hGle1-scrSD peptide had no effect. To
confirm the in situ hybridization experiments, we analyzed
the relative amounts of DHFR mRNA in cytoplasmic and
nuclear fractions isolated from HeLa cells pretreated with
the peptides (Fig. 4 E). Using a semiquantitative RT-PCR
strategy, the presence of AP–hGle1-SD peptide markedly
decreased the levels of DHFR transcript in the cytoplasmic
fraction. Moreover, there was a corresponding increase
in the nuclear signal relative to the control AP–hGle1-
scrSD–treated cells. Together, the in situ hybridization ex-
periments and biochemical fractionation data confirm that
AP–hGle1-SD peptide impairs the export of mRNA from
the nucleus.
To test whether the decrease in mRNA export resulted
from a general perturbation of transport through NPCs,
protein import and export activity was analyzed. For nuclear
import, cells transiently expressing a glucocorticoid receptor
(GR) GFP fusion protein were treated with AP–peptides for
4 h (Fig. 5 A). In the absence of the agonist dexamethasone,
a substantial GR–GFP cytoplasmic pool was observed.
When dexamethasone was added to induce import, nuclear
accumulation of GR–GFP was observed in the presence of
either peptide. To determine if protein export from the nu-
cleus was perturbed, the intracellular distribution of karyo-
pherin/importin  1 was monitored by IIF. We hypothesized
that if the general nuclear protein export pathways were af-
fected by AP–hGle1-SD peptide, karyopherin/importin  1
would accumulate in the nucleus of treated cells. However,
the cellular distribution of this shuttling karyopherin was
not affected (Fig. 5 B). Thus, protein import and export are
not markedly inhibited under conditions where AP–hGle1-
SD decreases poly(A)
  RNA export. These data suggest that
hGle1-SD function is specifically essential for the mRNP ex-
port process.
Figure 4. The AP–hGle1-SD peptide results in nuclear poly(A)
  
RNA accumulation. (A) Schematic representation of the cell-permeable 
peptides used. AP–hGle1-SD, antennapedia 16–amino acid leader 
peptide (AP) followed by hGle1 amino acids 444–483 (hGle1-SD) 
or followed by randomly scrambled sequence of identical SD 
composition (AP–hGle1-scrSD). (B) In situ hybridization experiments 
detect nuclear poly(A)
  RNA accumulation in AP–hGle1-SD–treated 
cells. HeLa cells ( 10 passages) were incubated for 4 h with 5  M 
of AP–hGle1-SD (SD) or the control AP–hGle1-scrSD peptide 
(scrSD) in normal growth medium. In situ hybridization using 
digoxigenin-labeled oligo(dT)30 detected total poly(A)
  RNA. Nuclear 
DNA was visualized by DAPI staining. *, cell undergoing apoptosis. 
(C) Poly(A)
  RNA distribution in untreated HeLa cells shows distri-
bution similar to AP–hGle1-scrSD–treated cells. (D) AP–hGle1-SD 
impairs nuclear export of DHFR mRNA. Cells treated with AP–peptides 
were processed for in situ hybridization using a digoxigenin-labeled 
DNA probe against DHFR mRNA. Bar, 10  m. (B–D) Respective 
hybridization signals represent equivalent exposure times. (E) Semi-
quantitative analysis of intracellular DHFR mRNA distribution in 
subcellular fractions of AP–peptide-treated cells. After treatment 
with peptides, total RNA from nuclear and cytoplasmic fractions 
was isolated and reverse transcribed with oligo (dT)18, and serial 
dilutions were made. Subsaturating PCR-based amplifications with 
DHFR-specific primers were performed (see Materials and methods), 
and products were separated on agarose gels and stained with 
ethidium bromide.T
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Inhibition of hGle1-SD activity by AP–hGle1-SD 
peptide perturbs endogenous hGle1 localization 
at NPCs
In parallel with the study of poly(A)
  RNA distribution, we
analyzed the localization of endogenous hGle1 by IIF micros-
copy in cells treated with AP–peptides. Different permeabili-
zation and fixation conditions were used to discriminate be-
tween cytoplasmically accessible hGle1 and nuclear hGle1
(Fig. 6). In untreated wild-type cells processed by fixation
and complete Triton X-100 permeabilization (Fix-Triton), a
pool of hGle1 is localized at the NPC/NE, and a fraction of
the hGle1 is cytoplasmically accessible (Watkins et al., 1998;
Fig. 1 A). In cells treated with the control AP–hGle1-scrSD
peptide and processed by Fix-Triton, endogenous hGle1 was
localized in a typical wild-type pattern, and cells exhibited
normal poly(A)
  RNA distribution (Fig. 6 A, top). However,
when cells were treated with the AP–hGle1-SD peptide, dis-
tinct hGle1 staining at the NPC/NE was less apparent in cells
with impaired poly(A)
  RNA export (Fig. 6 A, bottom).
To further analyze the perturbations in hGle1 localization
induced by the AP–hGle1-SD peptide, cells were treated
with digitonin alone to selectively permeabilize the plasma
membrane before fixation (Digitonin-Fix; Fig. 6 B). Under
these conditions, very little anti-hGle1 staining was observed
in cells affected by the AP–hGle1-SD peptide (Fig. 6 B, as-
terisks). This contrasted with the strong signal detected in
AP–hGle1-scrSD cells and in an unaffected cell (Fig. 6 B, ar-
rowheads). The lack of anti–lamin B staining in similarly
treated Digitonin-Fix cells served as a control for NE integ-
rity. To visualize the intranuclear distribution of hGle1, cells
were permeabilized with digitonin, fixed, and then incu-
bated with Triton X-100 (Digitonin-Fix-Triton). By this
method, cells treated with the control AP–hGle1-scrSD
showed uneven and low levels of nucleoplasmic hGle1 (Fig.
6 C). The AP–hGle1-SD cells seemed to show a slight in-
crease in nucleoplasmic levels; however, the intranuclear
staining pattern was not significantly changed. Western
blotting confirmed that the hGle1 protein size and levels
were not altered in the presence of the AP–hGle1-SD pep-
tide (not depicted).
To more directly address the effect of AP–hGle1-SD on
hGle1 nucleocytoplasmic shuttling, we analyzed the distribu-
tion of microinjected GST–hGle1A in cells treated with the
AP–hGle1-SD peptide. Compared with the control AP–
hGle1-scrSD cells, the presence of the AP–hGle1-SD peptide
resulted in less efficient import of cytoplasmically injected
GST–hGle1A into the nucleus (90   2.5%; n   49 microin-
jected HeLa cells) (Fig. 7 A, left). Similarly, the AP–hGle1-
SD peptide impaired the export of nuclear-injected GST–
hGle1A (88.5   3%; n   43 injected cells) (Fig. 7 A, right).
To confirm that the hGle1 mislocalization was not due to
a general perturbation of the NPC or NE structure, the dis-
tribution of nucleoporins recognized by mAb414 (including
p62; Davis and Blobel, 1986) was examined. Cells treated
with AP–hGle1-SD peptide and accumulating nuclear
poly(A)
  RNA showed mAb414 staining at the NPC/NE
(Fig. 7 B, bottom) that was similar to the control (Fig. 7 B,
top) and untreated cells (Fig. 1 A). Thus, the treatment with
AP–hGle1-SD peptide and inhibition of poly(A)
  RNA had
no adverse effect on global NPC structure/composition.
Figure 5. Nuclear protein import and export are not perturbed 
in HeLa cells treated with AP–peptides. (A) HeLa cells transfected 
with a GR–GFP expression vector were treated with 5  M of AP–
peptide. Dexamethasone (Dex ) or an equivalent volume of ethanol 
(Dex ) was added in the last 30 min before fixation and DAPI 
staining. Dexamethasone addition specifically induces nuclear 
import of the cytoplasmic GR–GFP pool in the presence of either 
peptide. (B) Karyopherin/importin  1 (Kap 1) intracellular local-
ization in AP–hGle1-SD– and control peptide (scrSD)–treated cells 
is not perturbed. Cells were treated with peptides as described 
above, fixed, and processed for IIF using anti-Kap 1 antibodies. 
Bars, 10  m.T
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Overall, we concluded that competing for the hGle1-SD–
interacting factor(s) resulted in coincident nuclear accumu-
lation of mRNA, decreased the endogenous hGle1 fraction
associated with the cytoplasmic NPC face, and reduced the
nucleocytoplasmic shuttling of GST–hGle1 protein.
Discussion
In this report, we have addressed the question of whether
hGle1 is a stable component of the NPC or if instead it be-
haves as a shuttling transport factor. Our results support the
conclusion that although the major hGle1 isoform (hGle1B)
Figure 6. AP–hGle1-SD peptide results in mislocalization of 
endogenous hGle1 localization when poly(A)
  RNA export is 
inhibited. HeLa cells were incubated with AP–hGle1-SD (SD) or 
control peptide (scrSD), processed for IIF using affinity-purified anti-
hGle1 antibodies (A–C), and in situ hybridized with oligo (dT)30 (A) 
or stained with DAPI (B and C). Hybridized probe and bound hGle1 
antibodies were simultaneously detected using rhodamine-labeled 
anti–Dig Fab antibodies and FITC-labeled anti–rabbit antibodies, 
respectively. Images showing in situ hybridization results reflect 
equivalent exposure times. (A) Fix-Triton permeabilization detects 
total hGle1 pool and shows changes in anti-hGle1 localization in 
AP–hGle1-SD–treated cells. (B) Digitonin-Fix permeabilization detects 
only the cytoplasmically accessible pool. AP–hGle1-SD results in 
decreased levels of cytoplasmically accessible hGle1 (asterisk) 
compared with unaffected cells (arrowheads, at passage  150; see 
Materials and methods) or cells treated with control peptide. The 
absence of lamin B staining using anti–lamin B antibodies (far right) 
confirms NE integrity under these conditions. (C) Detection of 
nuclear hGle1 was accomplished by combined Digitonin-Fix-Triton 
permeabilization. Lamin B staining confirms access of antibodies to 
intranuclear proteins. Bars, 10  m.
Figure 7. The AP–hGle1-SD peptide inhibits the shuttling of GST–
hGle1. (A) HeLa cells were pretreated with AP–peptides (3 h) and 
microinjected with GST–hGle1A in the cytoplasm (left) or nucleus 
(right) of the cells. After recovery (2 h), the intracellular distribution 
of GST–hGle1A was analyzed by IIF using anti-GST antibodies. 
Compared with cells treated with the scrSD control peptide, less 
GST–hGle1 is detected outside the microinjection site in the majority 
of cells analyzed. (B) NPC/NE association of nucleoporins recognized 
by mAb414 is not perturbed by AP–hGle1-SD treatment. HeLa cells 
incubated with AP–hGle1-SD (SD) or control peptide (scrSD) were 
processed for in situ hybridization with oligo(dT)30 and coincident 
IIF with mAb414. The mAb414 staining is similar in AP–hGle1-SD 
and scrSD cells despite the poly(A)
  RNA export defect in the AP–
hGle1-SD cells. Bars, 10  m.T
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in HeLa cells has a steady-state localization at the NPC, its
role in transport hinges on nucleocytoplasmic dynamics.
These conclusions are based on several pieces of evidence.
First, we identified a 39–amino acid domain in hGle1 that
has intrinsic nucleocytoplasmic shuttling activity. Second,
photobleaching (FLIP) of EGFP–hGle1B in live HeLa cells
shows that hGle1 shuttles. Third, we demonstrated that an
hGle1 39–amino acid domain is required for hGle1 nucleo-
cytoplasmic shuttling. Fourth, by disrupting the function of
the SD using a cell-permeable peptide strategy, we showed
that endogenous hGle1 association with NPCs is transient.
Finally, we observed that interfering with hGle1 shuttling
and NPC localization is coincident with a significant de-
crease in poly(A)
  RNA export. Overall, this pinpoints the
first functional motif in hGle1, demonstrates that hGle1 is a
shuttling mRNA export factor, and closely links hGle1 func-
tion to the dynamic mRNA export pathway.
We also report that two hGle1 isoforms are expressed in
HeLa cells, hGle1A and hGle1B. Both are identical except
for their very COOH-terminal regions. Two lines of evi-
dence suggest that the main hGle1 protein in HeLa cells
is hGle1B. First, in contrast to EGFP–hGle1A, EGFP–
hGle1B intracellular localization is highly similar to endoge-
nous hGle1. Second, semiquantitative RT-PCR experiments
show that hGle1B is the more abundant mRNA isoform in
HeLa cells. We speculate that the unique 43–amino acid re-
gion at hGle1B’s COOH terminus is required for NPC/NE
association. Interestingly, this region of hGle1B shares simi-
larities with scGle1 (Fig. 1 D), which is also predominately
localized at NPCs (Murphy and Wente, 1996; Rout et al.,
2000). Our future work will address whether each hGle1
isoform plays distinct in vivo roles.
Based on recent proteomic analysis of the mammalian
NPC (Cronshaw et al., 2002) and these studies, we conclude
that hGle1 is not a stable component of the NPC and that
hGle1 is not required for overall maintenance of NPC struc-
ture and function. In cells treated with AP–hGle1-SD pep-
tide, no perturbations in the localization of nucleoporins
recognized by mAb414, in GFP–GR protein import, or in
karyopherin/importin  1 nuclear export were detected. In
light of recent elegant reports on hNup153 (Nakielny et al.,
1999; Daigle et al., 2001), hNup98 (Griffis et al., 2002),
Npap60/Nup50 (Lindsay et al., 2002), and scNup2 (Dil-
worth et al., 2001), it is becoming evident that a subpopu-
lation of factors with steady-state NPC localization have
unexpected dynamic properties. We propose that hGle1B
transiently associates with NPCs during its function as a
shuttling mRNA export mediator.
Results from our photobleaching experiments and cell-
permeable peptide studies strongly support the conclusion
that endogenous hGle1 has a bona fide SD and dynamically
enters and exits the nucleus. In the presence of compet-
ing AP–hGle1-SD peptide, the association of endoge-
nous hGle1 with the NPC/NE was substantially reduced,
and the shuttling of recombinant hGle1 was severely im-
paired. Coincidentally, AP–hGle1-SD peptide induced nu-
clear poly(A)
  RNA accumulation, suggesting that hGle1 is
involved in a molecular cascade that leads to the export of
mRNP complexes out of the nucleus. It is possible that AP–
hGle1-SD peptide may compete for hGle1’s nucleoporin
binding site(s) or for an adaptor protein that bridges the in-
teraction of hGle1 with nucleoporins at NPCs. The latter
would be similar to the interaction networks of karyopherin/
importin  1 for   (Gorlich et al., 1995a,b) or Crm1 for Rev
(Fornerod et al., 1997). Alternatively, the SD peptide may
affect more than Gle1. If the unidentified SD-binding factor
has additional interacting partners, their interactions could
be equally perturbed. Thus, isolating an hGle1-SD–interact-
ing protein is of great interest. As a dynamic NPC-associated
protein, we speculate that hGle1 either actively participates
in the export process or facilitates the nuclear import of an
unidentified factor that would mediate mRNA export.
Interestingly, the amino acid sequence of the hGle1 SD is
not similar to any of the previously characterized nucleocyto-
plasmic SDs (Fig. 8). A direct alignment of the hGle1 SD
with the M9 of hnRNP A1 suggests weak similarity, which
could result in a potential interaction with the M9-binding
karyopherin  2A/transportin-1 (Siomi et al., 1997). How-
ever, the key consensus residues implicated in transportin-1
binding are not present in hGle1 (Pollard et al., 1996). We
tested for an hGle1-SD and transportin-1 interaction and
found that bacterially expressed GST–transportin-1 does not
directly bind immobilized hGle1-SD peptide (unpublished
data). This suggests that transportin-1 is not directly involved
in hGle1 shuttling. Further deletions within the hGle1 SD
and selective point mutations based on interspecies homol-
ogy analysis have not yet been successful in separating the nu-
clear import and export activities (unpublished data).
Although structurally similar to hGle1, the yeast homo-
logue scGle1 does not harbor a similar 39–amino acid pep-
tide sequence. Rather, the same region of scGle1 contains a
putative LR-NES–like motif (Murphy and Wente, 1996;
Watkins et al., 1998; Fig. 1 D). This motif in scGle1 is re-
quired for scGle1 function, suggesting that it may use the
Rev–Crm1 export pathway to exit the nucleus (Murphy and
Wente, 1996). Although the scGle1 putative LR-NES by it-
self mediates export in heterologous transport assays, an in-
Figure 8. Comparison of the hGle1 SD with nucleocytoplasmic 
shuttling sequences. The amino acid sequence of the hGle1 SD 
does not share significant similarities with other nucleocytoplasmic 
transport signals (Michael et al., 1995, 1997; Fan and Steitz, 1998). 
There are limited similarities with the hnRNP A1 M9 transport signal 
(boxed), but the hGle1 SD lacks the critical GPM triplet (asterisks) 
required for efficient transport activity of M9 (Bogerd et al., 1999).T
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teraction between scGle1 and scCrm1 has not been estab-
lished (Watkins et al., 1998; Stutz and Rosbash, 1998). It is
also unclear whether endogenous scGle1 shuttles. Taken to-
gether, the Gle1 mRNA export mechanisms in yeast and hu-
man cells may have subtle differences. Further studies in
yeast and human cells may reveal how two highly homolo-
gous proteins can function by potentially different mecha-
nisms and ultimately lead to a similar outcome, the export of
mature mRNPs from the nucleus.
Our work in this report strongly suggests that hGle1 dy-
namics are key to the poly(A)
  RNA export mechanism. It
will be of great interest to identify which factor(s) interacts
with hGle1A and B and, in particular, the hGle1 SD. We pre-
dict that this information will be valuable in ascertaining the
molecular cascade leading to hGle1-mediated mRNP export.
Materials and methods
Tissue culture cell experiments
HeLa cells were cultured in complete medium (DME; Invitrogen) supple-
mented with 10% FBS (Invitrogen Corp.), 10 mM sodium pyruvate, and
100 U/ml Pen/Strep at 37 C in 5% CO2. Cells were microinjected with the
Eppendorf InjectMAN micromanipulator using  2 mg/ml of recombinant
protein mixed with 1 mg/ml of TR-labeled 70-kD dextran (lysine fixable;
Molecular Probes) diluted in 10 mM phosphate buffer, pH 7.6, 75 mM
KCl. Transfections were done using Superfect
TM (QIAGEN) following the
manufacturer’s recommendations. 12–14 h later, transfected cells were
fixed and processed for IIF or direct EGFP fluorescence. Live cell imaging
was conducted as described by Griffis et al. (2002), except that imaging
media contained 10% FCS.
Cell-permeable peptide assay and nuclear import assay
Peptides were synthesized by FAST-moc chemistry and purified by re-
verse-phase HPLC, and the sequence was confirmed by mass spectrome-
try. Each peptide harbors the antennapedia sequence at its NH2 terminus
(RQIKIWFQNRRMKWKK) (Fig. 4 A). For assays, peptides were first diluted
in complete DME and added cells (CCL-2 cells; lot no. 2462426; passage
 10 after receipt from American Type Culture Collection) and grown to
70–80% confluency. After 4 h incubation, cells were processed for in situ
hybridization and/or IIF. We noted a decrease in the susceptibility of HeLa
cells after passage 150 from reception; 10% of the population appeared to
become resistant to the effects of AP–hGle1-SD peptide, likely due to di-
minished peptide uptake. This trend increases with passage number, ulti-
mately resulting in AP–hGle1-SD–resistant HeLa cell populations. Nuclear
import activity in AP–peptide-treated cells was determined after transfec-
tion with pK7.GR.GFP expression vector (Carey et al., 1996) and using
dexamethasone treatment (10  g/ml; Sigma-Aldrich).
IIF
HeLa cells were processed by three methods, Fix-Triton, Digitonin-Fix,
and Digitonin-Fix-Triton, as described by Watkins et al. (1998). The pri-
mary antibodies used were affinity-purified rabbit anti-GST (1:200), affin-
ity-purified rabbit anti-hGle1 (1:200; Watkins et al., 1998), rabbit anti–
lamin B (1:50; anti–peptide NC-6; gift of N. Chaudhary and G. Blobel, The
Rockefeller University, New York, NY), mAb414 (1:10; Davis and Blobel,
1986), rabbit anti-FLAG (1:200), and mouse anti–importin   (anti-p97;
1:1,000; Affinity BioReagents, Inc.). FITC-conjugated donkey anti–rabbit
(1:200) or FITC-conjugated donkey anti–mouse (1:200; Jackson Immu-
noResearch Laboratories) were used as secondary antibodies. Cells were
examined using an Olympus BX50 microscope. Digital images were re-
corded with a Photometric CoolSNAP HQ camera (Roper Scientific) using
MetaVue 6.0 software and digitally manipulated in Adobe Photoshop 7.0
®.
In situ hybridization
Cells were processed as described by Watkins et al. (1998). 3 -digoxige-
nin–labeled oligo(dT)30 probe was synthesized (Wente and Blobel, 1993)
and used at 7  g/ml. The 3 -digoxigenin–labeled DHFR probe comple-
mentary to nucleotides 530–569 of DHFR mRNA (Gallouzi and Steitz,
2001) was synthesized by Integrated DNA Technologies Inc. and used at
20  g/ml. After hybridization, cells were blocked for 1 h with 6% nonim-
mune sheep serum (Jackson ImmunoResearch Laboratories), and hybrid-
ized probes were detected with 1:200 sheep anti–digoxigenin Fab–
rhodamine (Roche Applied Science). For in situ/IIF double experiments,
polyclonal anti-hGle1 antibodies (1:200) or mAb414 (1:10) were used in
combination with 1:200 FITC-conjugated sheep anti–rabbit or sheep anti–
mouse (Sigma-Aldrich), respectively.
Cytoplasm/nuclear RNA isolation and RT-PCR
HeLa cells (5   10
6) treated or untreated with AP–peptides were scraped
off culture plates and suspended in ice cold RNase-free PBS. Nuclear and
cytoplasmic RNA fractions were isolated after the NP-40 lysis procedure
(Greenberg and Ziff, 1984), except that the lysis buffer was supplemented
with 1 mM DTT and 1 U/ L of RNAsin™ (Promega). Cell lysis was moni-
tored by bright field microscopy, and the integrity of the isolated nuclei
was confirmed by nucleoplasmic exclusion of the 70-kD TR-labeled dex-
tran (not depicted). Total RNA from each fraction was isolated using Tri-
zol™ reagent (Invitrogen). Genomic DNA contamination of the purified
cytoplasmic and nuclear RNA was estimated by PCR before reverse tran-
scription using the same conditions as below (not depicted). Each RNA
fraction was subsequently reverse transcribed using Superscript II™ and
random hexamers (Invitrogen) as per the manufacturer’s recommenda-
tions. Serial dilutions of the resulting cDNAs were made, and 10% of each
was used in PCR studies. For DHFR gene amplification (28 cycles), specific
primers (forward, 5 -CAGAACATGGGCATCGGCAAGAACG-3 ; reverse,
5 -AAACAGAACTGCCACCAACTATCCA-3 ) were used. 50% of each re-
action was separated by electrophoresis through a 1.7% agarose gel
stained with ethidium bromide. Amplification of hGle1A and hGle1B was
conducted using the above conditions and a common forward primer, F
(5 -ATACCAGGTCAGTTCTGGAAGATGC-3 ), with the respective A-spe-
cific reverse primer (5 -TCAACGAGAGGGACTGGAC-3 ) or B-specific re-
verse primer (5 -AGGAGCGCCAGAAGGAGG-3 ).
Plasmid constructs
Cloning of hGle1 cDNA isoforms. IMAGE clone no. 22734 was used to gen-
erate full-length hGle1A NH2-terminally tagged with EGFP (pSW1409;
CLONTECH Laboratories, Inc.) or FLAG (pSW1102). Based on partial EST
sequence information, hGle1B-specific primers were designed and used to
generate a 2.3-kbp fragment by using the Herculase™ polymerase mix
(Stratagene) and PCR. hGle1B cDNA was subsequently cloned into
pEGFP-C1 (pSW1482; CLONTECH Laboratories, Inc.). 
FLAG–hGle1 –NLS constructs. Oligonucleotides encoding the SV40
large T antigen NLS were annealed and cloned at the 3  end of FLAG–
hGle1A, yielding FLAG–hGle1A–NLS (pSW1116). Digestion of pSW1116
with BglII generated FLAG–hGle1 444–606–NLS (pSW1127). Deletions of the
hGle1 444–606 region were made by PCR and cloned back into
pSW1127, generating pSW1190 (FLAG–hGle1 444–541–NLS), pSW1206
(FLAG–hGle1 444–511–NLS), pSW1416 (FLAG–hGle1 511–606–NLS), and
pSW1415 (FLAG–hGle1 484–606–NLS).
GST expression constructs. Full-length hGle1A and B were cloned in
frame with GST in pGex-3X series (AP Biotech) (pSW728 and pSW1487,
respectively). These were used to generate pGex-hGle1A 444–483
(pSW1407) and pGex-hGle1B 444–483 (pSW1496). An hGle1 DNA fragment
coding for region 444–483 was amplified by PCR from IMAGE clone
no. 22734 and cloned into pGex 5X-2 (AP Biotech), yielding pGex-
hGle1444–483 (SD) (pSW1412).
Purification of recombinant proteins
GST fusion proteins were expressed in BL21 cells and purified according
to the manufacturer’s instructions (AP Biotech), except cells were lysed by
French press (12,000 PSI). After affinity chromatography, fusion proteins
were eluted with 15 mM reduced glutathione (Sigma-Aldrich) in 150 mM
NaCl, 50 mM Tris, pH 8.5. Eluates were dialyzed against microinjection
buffer (10 mM phosphate buffer, pH 7.6, 75 mM KCl) and stored at  70 C.
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